Healthline lands Drugs.com ad sales deal

Share this article:
Healthline lands Drugs.com ad sales deal
Healthline lands Drugs.com ad sales deal
Healthline Networks has secured a deal with Drugs.com giving it exclusive rights to sell consumer ads on the site, which boasts 8.8 million unique visitors per month.

The agreement boosts Healthline's reach to nearly 55 million monthly uniques, said the San Francisco firm, or about half the monthly health information audience, per comScore stats.

“We wanted a partner that could help marketers take advantage of our critical position in the treatment consideration process,” said Drugs.com CEO Philip Thornton. “Healthline not only gives us a roster of strategic sellers with deep DTC experience but original, engaging content and visual learning solutions that can help marketers reach consumers and healthcare providers at a critical point of decision.”

Healthline, whose backers include Kaiser Permanente, Reed Elsevier, GE/NBC Peacock Fund and Aetna, offers search, advertising and content services through partnerships with 50-plus destination sites including web publishers, portals, search engines, employers and health plans.
Share this article:

Email Newsletters

More in News

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...

Pfizer Q2 sales slip, but still beat expectations

Pfizer Q2 sales slip, but still beat expectations

Patent losses and lost co-promotion agreements put a dent in sales.

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?